modified human PTH (Rhein-Minapharm)

N/A

Report date: 2025/03/20 16:07:44

Base Information

Drug Namemodified human PTH (Rhein-Minapharm)
Drug Alias Namemodified human parathyroid hormone (Rhein)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis +[3] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRhein Minapharm Biogenetics
China Registration ClassN/A

Develop Information

Active CompaniesRhein Minapharm Biogenetics
Inactive CompaniesN/A
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis +[3] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A